bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide has been researched along with Dyskinesia Syndromes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruinvels, J; Cools, AR; van der Laan, JW | 1 |
Dolphin, A; Jenner, P; Marsden, CD | 1 |
2 other study(ies) available for bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide and Dyskinesia Syndromes
Article | Year |
---|---|
Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: participation of the locus coeruleus system.
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Disease Models, Animal; Humans; Locus Coeruleus; Male; Morphine; Movement Disorders; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Valproic Acid | 1982 |
Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Dopamine beta-Hydroxylase; Imidazoles; Levodopa; Mice; Motor Activity; Movement Disorders; Reserpine; Time Factors | 1975 |